Publications

Our commitment to advancing surgical robotics is supported by peer-reviewed clinical evidence across our technology platforms. Geniant® Cranial received FDA clearance in January 2025 and is marketed in the United States. Research from our predecessor system, which received MFDS approval in July 2016 and is marketed in South Korea, is included below for reference.

Year

  Title

Authors

Link

2025

Safety and efficacy of stereoelectroencephalography using a novel robot based on the center-of-arc principle in patients with medically refractory epilepsy

Junhyung Kim et al.
DOI

Year

2025

Title

Safety and efficacy of stereoelectroencephalography using a novel robot based on the center-of-arc principle in patients with medically refractory epilepsy

Authors

Junhyung Kim et al.

Link

DOI
Contact

geniant@kohyoung.com

12230 World Trade Drive, Suite 200
San Diego, CA 92128 USA

© 2026 Koh Young Technology Inc. All rights reserved. GENIANT® is a registered trademark of Koh Young Technology Inc. in the United States and other countries. The stylized Geniant logo and other Geniant product names referenced herein are trademarks of Koh Young Technology Inc. All other trademarks are the property of their respective owners. Some products may not be available in your country or region. Please contact your local Geniant representative for more information.